DE69530787D1 - Auf die leber zielende verbindungen und reagentien zu deren herstellung - Google Patents

Auf die leber zielende verbindungen und reagentien zu deren herstellung

Info

Publication number
DE69530787D1
DE69530787D1 DE69530787T DE69530787T DE69530787D1 DE 69530787 D1 DE69530787 D1 DE 69530787D1 DE 69530787 T DE69530787 T DE 69530787T DE 69530787 T DE69530787 T DE 69530787T DE 69530787 D1 DE69530787 D1 DE 69530787D1
Authority
DE
Germany
Prior art keywords
hexose
compounds
directed
hepatic
configuration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69530787T
Other languages
English (en)
Other versions
DE69530787T2 (de
Inventor
Louis J Theodore
Donald B Axworthy
John M Reno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poniard Pharmaceuticals Inc
Original Assignee
Poniard Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poniard Pharmaceuticals Inc filed Critical Poniard Pharmaceuticals Inc
Publication of DE69530787D1 publication Critical patent/DE69530787D1/de
Application granted granted Critical
Publication of DE69530787T2 publication Critical patent/DE69530787T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
    • A61K47/6893—Pre-targeting systems involving an antibody for targeting specific cells clearing therapy or enhanced clearance, i.e. using an antibody clearing agents in addition to T-A and D-M
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0465—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Nanotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69530787T 1994-12-07 1995-12-06 Auf die leber zielende verbindungen und reagentien zu deren herstellung Expired - Fee Related DE69530787T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US351651 1989-05-15
US08/351,651 US5886143A (en) 1994-12-07 1994-12-07 Hepatic-directed compounds and reagents for preparation thereof
PCT/US1995/015875 WO1996017613A1 (en) 1994-12-07 1995-12-06 Hepatic-directed compounds and reagents for preparation thereof

Publications (2)

Publication Number Publication Date
DE69530787D1 true DE69530787D1 (de) 2003-06-18
DE69530787T2 DE69530787T2 (de) 2004-06-03

Family

ID=23381756

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69530787T Expired - Fee Related DE69530787T2 (de) 1994-12-07 1995-12-06 Auf die leber zielende verbindungen und reagentien zu deren herstellung

Country Status (7)

Country Link
US (2) US5886143A (de)
EP (1) EP0794788B1 (de)
JP (1) JP2001525790A (de)
AT (1) ATE240109T1 (de)
CA (1) CA2207096A1 (de)
DE (1) DE69530787T2 (de)
WO (1) WO1996017613A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968477A (en) * 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
CA2180555C (en) * 1994-01-24 2004-12-14 Sudhakar Kasina Radiolabeled annexins
US6172045B1 (en) * 1994-12-07 2001-01-09 Neorx Corporation Cluster clearing agents
WO1997046099A1 (en) * 1996-06-06 1997-12-11 Neorx Corporation Liver retention clearing agents
DE19755367C2 (de) * 1997-12-12 2001-03-22 Afting Ernst Guenter Pharmazeutische Zusammensetzung enthaltend D-Galaktose und ihre Verwendung
US6811996B1 (en) * 1998-10-30 2004-11-02 Daiichi Pharmaceutical Co., Ltd. DDS compounds and method for assaying the same
SI1530482T1 (sl) 2002-07-18 2014-03-31 Helix Biopharma Corp. Uporaba ureaze za inhibiranje rasti rakavih celic
JP4430344B2 (ja) * 2002-09-09 2010-03-10 独立行政法人科学技術振興機構 多岐用途型リンカー化合物及びリガンド、並びにそれらの製造方法
WO2006041613A2 (en) * 2004-10-05 2006-04-20 Nanomega Medical Corporation Nanoparticles for targeting hepatoma cells
US9239329B2 (en) * 2006-12-18 2016-01-19 Japan Science And Technology Agency Method of measuring interaction between biomaterial and sugar chain, method of evaluating biomaterial in sugar chain selectivity, method of screening biomaterial, method of patterning biomaterials, and kits for performing these methods
US9518087B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
RU2013133813A (ru) 2010-12-21 2015-01-27 Конинклейке Филипс Электроникс Н.В. Средства для выведения биомолекул из кровотока
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
EP3909603A1 (de) 2014-02-21 2021-11-17 Ecole Polytechnique Fédérale de Lausanne (EPFL) Glycotargeting-therapeutika
WO2018232176A1 (en) 2017-06-16 2018-12-20 The University Of Chicago Compositions and methods for inducing immune tolerance
IL294515A (en) 2020-01-31 2022-09-01 Avilar Therapeutics Inc Compounds bind asgpr to degrade extracellular proteins

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4410688A (en) * 1981-04-29 1983-10-18 Allied Corporation Macromolecular highly branched homogeneous compound
US4568737A (en) * 1983-01-07 1986-02-04 The Dow Chemical Company Dense star polymers and dendrimers
US4507466A (en) * 1983-01-07 1985-03-26 The Dow Chemical Corporation Dense star polymers having core, core branches, terminal groups
US4558120A (en) * 1983-01-07 1985-12-10 The Dow Chemical Company Dense star polymer
US4587329A (en) * 1984-08-17 1986-05-06 The Dow Chemical Company Dense star polymers having two dimensional molecular diameter
US4897255A (en) * 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5045303A (en) * 1985-05-17 1991-09-03 Neorx Corporation Radiohalogenated small molecules for protein labeling
US5554386A (en) * 1986-07-03 1996-09-10 Advanced Magnetics, Inc. Delivery of therapeutic agents to receptors using polysaccharides
US5057302A (en) * 1987-02-13 1991-10-15 Abbott Laboratories Bifunctional chelating agents
US4965392A (en) * 1987-03-26 1990-10-23 Neorx Corporation Chelating compounds for metal-radionuclide labeled proteins
US5166320A (en) * 1987-04-22 1992-11-24 University Of Connecticut Carrier system and method for the introduction of genes into mammalian cells
GB8809616D0 (en) * 1988-04-22 1988-05-25 Cancer Res Campaign Tech Further improvements relating to drug delivery systems
CA2070647C (en) * 1989-12-27 2001-04-10 Christiaan Reutelingsperger Use of an anticoagulant as a diagnostic agent
US5552525A (en) * 1991-02-08 1996-09-03 Diatech Inc. Technetium-99m labeled peptides for imaging inflammation
US5310536A (en) * 1992-02-06 1994-05-10 Mallinckrodt Medical, Inc. Ligands for improving metal chelate formation kinetics
US5624896A (en) * 1992-06-09 1997-04-29 Neorx Corporation Clearing agents useful in pretargeting methods

Also Published As

Publication number Publication date
EP0794788B1 (de) 2003-05-14
ATE240109T1 (de) 2003-05-15
JP2001525790A (ja) 2001-12-11
US5985826A (en) 1999-11-16
DE69530787T2 (de) 2004-06-03
EP0794788A1 (de) 1997-09-17
EP0794788A4 (de) 2000-05-24
WO1996017613A1 (en) 1996-06-13
US5886143A (en) 1999-03-23
CA2207096A1 (en) 1996-06-13

Similar Documents

Publication Publication Date Title
DE69530787D1 (de) Auf die leber zielende verbindungen und reagentien zu deren herstellung
US4224769B1 (de)
PT983286E (pt) Compostos de aminoalquil-glicosamina-fosfato e sua utilizacao como adjuvantes eimunoefectores
DE3875631D1 (de) System zur herstellung einer arbeitsumgebung.
DE3770646D1 (de) Vielfach-sichtsystem.
ATE71653T1 (de) Enzymatisches persaeure-bleichmittelsystem.
DE3850919D1 (de) Diagnostisches Assay mit signalentwickelndem Agens auf dem Träger.
EP0251584A3 (de) Synchronisationsverwaltung für ein verteiltes Betriebssystem oder ähnliche Systeme
DE3751071D1 (de) Verpackung für landwirtschaftliche Produkte.
DE3863703D1 (de) Spielfreies planetengetriebe.
DE69018675D1 (de) Umlaufrädergetriebesystem.
ATE63556T1 (de) Makrolid-derivate, verfahren zu ihrer herstellung und ihre verwendung.
FI871691A0 (fi) Klockrenegeringsarrangemang tillaempligt speciellt pao ett informationstransmissionssystem som anvaender den tiddelade fleraotkomstprincipen i en transmissionsriktning.
DE69022342D1 (de) Planetengetriebesystem.
ES2171704T3 (es) Peptidos ciclicos analogos de somatostatina con actividad inhibidora sobre la hormona del crecimiento.
DE69010747D1 (de) Bodenverbesserung für Baumanpflanzungen.
FI872943A (fi) Reaktor avsedd foer att alstra biogas.
DE59106810D1 (de) Koppelfeld für ein asynchrones Zeitvielfachübermittlungssystem.
FR2652134B1 (fr) Dispositif d'assemblage de tiges ou de tous autres elements longilignes tels que broches, cables, fils, barres, tiges ou autres.
ES2066422T3 (es) Expresion de un arn multigenes con actividad de autoempalme.
DE3581257D1 (de) Hybrid-samenproduktion bei gemeinem weizen durch gebrauch von cytoplasmischer maennlicher sterilitaet.
SU691341A1 (ru) Устройство дл заводки гребных валов
IT1242056B (it) Mietitrice di cotone.
NL194904B (nl) Mannelijke steriele plant.
FI880155A0 (fi) Eldfast foder foer en konverter.

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee